Toth Financial Advisory Corp Eye Point Pharmaceuticals, Inc. Transaction History
Toth Financial Advisory Corp
- $795 Million
- Q1 2025
A detailed history of Toth Financial Advisory Corp transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Toth Financial Advisory Corp holds 2,001 shares of EYPT stock, worth $13,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,001
Previous 1,001
99.9%
Holding current value
$13,166
Previous $7,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EYPT
# of Institutions
158Shares Held
72.8MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$54.8 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$44.6 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$37.8 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$27.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$25 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $224M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...